Keyphrases
Anticancer Drugs
100%
Adriamycin
100%
Combination Chemotherapy
100%
Chronotherapy
100%
Docetaxel
100%
Dosing Schedule
100%
Metastatic Breast Cancer
75%
Dosing Time
75%
Dose Rate
75%
Adverse Effects
50%
Severe Adverse Effects
50%
Tumor Growth
25%
Clinical Application
25%
Combination Therapy
25%
Biological Function
25%
Clinical Practice
25%
Biological Rhythms
25%
Circadian Rhythm
25%
Living Organisms
25%
Antitumor Effect
25%
Inhibition Rate
25%
Interval Time
25%
Median Survival
25%
Optimal Dosing
25%
Therapeutic Outcome
25%
Schedule-based
25%
Toxic Death
25%
Leukopenia
25%
Therapeutic Index
25%
Medication Administration
25%
Sequence Time
25%
Time Cycle
25%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Chemotherapy
100%
Adverse Event
100%
Doxorubicin
100%
Chronotherapy
100%
Docetaxel
100%
Metastatic Breast Cancer
75%
Combination Therapy
25%
Tumor Growth
25%
Anticarcinogen
25%
Leukopenia
25%
Therapeutic Window
25%